An index of captured practitioner sources, not a completed evidence summary. Unchecked figures and empty sections are omitted. See the library review status.
Source summary generated July 17, 2026; this date does not indicate completed review.
Quotes from three independent practitioners, with their sources. Research context only.
What it is and how it works
From the published literature on Metformin; the papers are listed at the end. Research summary, not a recommendation.
What it is
Metformin is a small synthetic molecule of the biguanide class, not a peptide. It descends from guanidine compounds found in French lilac (goat's rue), a folk remedy for diabetes, and was introduced in Europe in the late 1950s and approved by the FDA in 1994. It is a first-line, FDA-approved prescription drug for type 2 diabetes and one of the most prescribed medicines in the world; interest in it for healthy ageing comes from observational and animal data and a planned aging trial, not from an approved use.
How it works
Metformin's main effect is to lower the amount of glucose the liver releases into the blood, especially overnight and between meals. It does this partly by mildly slowing complex I of the mitochondria (the cell's energy factories), which shifts the liver cell's energy balance and switches on AMPK, an enzyme that acts as a cellular fuel gauge and turns down glucose and fat production. More recent work also points to effects in the gut, where it raises the release of the hormone GLP-1, changes the gut bacteria and increases glucose use by the intestine. Unlike insulin or sulfonylureas it does not push the pancreas to release more insulin, so on its own it rarely causes low blood sugar.
What it has been studied for
Blood-sugar control and complications in type 2 diabetes (large randomized trials; FDA approved)
Preventing type 2 diabetes in people at high risk (large randomized trial)
Healthy ageing and age-related disease (reviews and a proposed aging trial)
Interaction with exercise training in older adults (randomized placebo-controlled trials)
Use in people with reduced kidney function (systematic review)
Strength of the evidence
Approved drugMetformin is FDA-approved for type 2 diabetes with decades of randomized-trial and outcome data; its use for ageing or longevity has no approval and rests on observational and animal evidence.
What the literature reports on safety
The FDA label lists stomach upset, diarrhoea and nausea as the most common side effects and carries a boxed warning for lactic acidosis, a rare but serious build-up of acid in the blood, mainly with significantly reduced kidney function, liver disease, heavy alcohol use, or around iodinated contrast imaging; a systematic review found that use with mild to moderate kidney impairment was reasonable with appropriate adjustment. Long-term use is associated with lower vitamin B12 levels. In randomized trials in older adults metformin blunted gains from exercise training, reducing the mitochondrial improvement from aerobic training and the muscle gain from resistance training.
Review · Foretz M, Guigas B, et al. · Nature Reviews Endocrinology (2023) · PMID 37130947
Reviewed how metformin lowers liver glucose output, its effects on mitochondria, AMPK and the gut, and the evidence for repurposing it in cancer, ageing and other conditions.
Weighed the competing explanations for how metformin works, including changes in the liver cell's redox state and energy balance and actions in the intestine.
Randomized trial · UK Prospective Diabetes Study (UKPDS) Group · Lancet (1998) · PMID 9742977
In overweight people with newly diagnosed type 2 diabetes, metformin reduced diabetes-related endpoints by 32% and all-cause death by 36% compared with conventional diet-based treatment.
Review · Barzilai N, Crandall JP, et al. · Cell Metabolism (2016) · PMID 27304507
Laid out the animal and observational evidence behind the proposed TAME trial, which aims to test whether metformin delays age-related diseases in people without diabetes.
Answers are generated from captured sources and may omit context or contain errors. Check the supporting passages.
What have the teachers said about Metformin? Ask what it is, what they say it does, or where they discuss it. Questions about doses or personal use: ask your own clinician.
AI chat. To generate a reply, your question and recent chat history may be processed by Cloudflare Workers AI, Groq, Google Gemini or OpenRouter, depending on availability. Keep personal health details out of the chat and check the cited sources. Research use only; not medical advice.
All content on this page is for research and educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any peptide or hormone protocol. You take responsibility for your own protocol.If your path includes peptides, you buy them yourself from an independent licensed provider through a member co-op; we take nothing. How independent access works.